Mikko I. Mäyränpää
-
- Viral Infections and Immunology Research 9
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 11
- Mast cells and histamine 8
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Occupational and environmental lung diseases 8
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 8
- Physiology top 5%
- Sarcoidosis and Beryllium Toxicity Research 10
-
- Cholesterol and Lipid Metabolism 7
- Co-authors
- Petri T. KovanenKen A. LindstedtMarkku KupariSatu HelskeKalervo WerkkalaJyri LommiJesper SwedenborgHeikki Turto
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)Journal of the American College of Cardiology (2 papers)
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Mikko I. Mäyränpää
95 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cardiology and Cardiovascular Medicine 742
- Immunology 532
- Pulmonary and Respiratory Medicine 736
- Cancer Research 274
- Physiology 459
Countries citing papers authored by Mikko I. Mäyränpää
This map shows the geographic impact of Mikko I. Mäyränpää's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko I. Mäyränpää with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko I. Mäyränpää more than expected).
Fields of papers citing papers by Mikko I. Mäyränpää
This network shows the impact of papers produced by Mikko I. Mäyränpää. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko I. Mäyränpää. The network helps show where Mikko I. Mäyränpää may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mikko I. Mäyränpää, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 33 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 55 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2018 | 18 | |
| 18 | 2018 | 11 | |
| 19 | 2012 | 11 | |
| 20 | 2008 | 40 |
About Mikko I. Mäyränpää
Mikko I. Mäyränpää is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Immunology and Allergy, having authored 100 papers that have together received 2.8k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Sarcoidosis and Beryllium Toxicity Research (10 papers), Viral Infections and Immunology Research (9 papers), Protease and Inhibitor Mechanisms (8 papers), Occupational and environmental lung diseases (8 papers), Mast cells and histamine (8 papers) and Cholesterol and Lipid Metabolism (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (742 citations), Immunology (532 citations) and Pulmonary and Respiratory Medicine (736 citations). Mikko I. Mäyränpää has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Petri T. Kovanen, Ken A. Lindstedt, Markku Kupari, Satu Helske, Kalervo Werkkala, Jyri Lommi, Jesper Swedenborg, Heikki Turto, Jukka Lehtonen and Mika Laine. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.